Jeff Yass’s Allergan plc AGN.PRA Stock Holding History

Jeff Yass’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-392	Closed	-$230K	–	10809
2017 Q4	$230K	Buy	+392	New	+$253K	﹤0.01%	8032
2016 Q4	–	Sell	-5,000	Closed	-$4.11M	–	10509
2016 Q3	$4.11M	Sell	5,000 -3,000	-38%	-$2.59M	﹤0.01%	2479
2016 Q2	$6.67M	Buy	+8,000	New	+$6.68M	﹤0.01%	1859
2016 Q1	–	Sell	-19,050	Closed	-$19.5M	–	10113
2015 Q4	$19.5M	Buy	19,050 +2,500	+15%	+$2.51M	0.01%	1169
2015 Q3	$15.6M	Sell	16,550 -1,900	-10%	-$1.98M	0.01%	1427
2015 Q2	$19.5M	Buy	+18,450	New	+$19.3M	0.01%	1327

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Jeff Yass's AGN.PRA Position: Q1 2018 in Review

Jeff Yass sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 392 shares — an estimated $230K sold.

Jeff Yass first reported a position in AGN.PRA in Q2 2015 and held it in 6 quarters. The position peaked at $19.5M in Q4 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Jeff Yass reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Jeff Yass sold 392 Allergan plc shares in Q1 2018, an estimated $230K.
Jeff Yass first reported a position in Allergan plc in Q2 2015 and held it in 6 quarters.
Jeff Yass's Allergan plc position peaked at $19.5M in Q4 2015.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.